A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With Asthma

NCT ID: NCT01244984 Phase: PHASE3 Status: COMPLETED Enrollment: 243 Completion: 2012-01

Conditions

Asthma

Interventions

Fluticasone Furoate/GW642444 Inhalation Powder, Fluticasone Furoate Inhalation Powder

Summary

The primary purpose of the study is to assess the safety and tolerability of 52-week teatment with fluticasone furoate/GW642444 inhalation powder once-daily and FF inhalation powder once-daily in Japanese adult subjects with asthma.

Primary Outcome

Number of Participants With Any Non-serious Adverse Event (AE) and Any Serious Adverse Event (SAE)

Source

ClinicalTrials.gov